A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes

Completed · Phase 1

Conditions studied: Carcinoma, Renal Cell

In brief

This is a Phase I study to determine the effect of GW786034 (pazopanib) on P450 enzymes. This study will help determine which types of drugs may interact with GW786034.

Key facts

Study ID
NCT00401583
Run by
GlaxoSmithKline
People needed
24
Starts
2006-07-28
Expected to finish
2008-02-20
Last updated by the study team
2017-11-13

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.